VDAC1 SILENCING MOLECULES AND USE THEREOF

Research output: Patent

Abstract

The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.

Original languageEnglish
Patent numberWO2020089906
IPCA61P 35/ 00 A I
Priority date27/06/19
StatePublished - 7 May 2020

Fingerprint

Dive into the research topics of 'VDAC1 SILENCING MOLECULES AND USE THEREOF'. Together they form a unique fingerprint.

Cite this